In one study, in MS patients who received IFNγ (resulting in a condition called flu-like syndrome), possessing the A allele of this SNP did not alter any of the syndrome symptoms measured, including general malaise, muscle pain, chills, weakness and the need to take non-steroidal anti-inflammatory drugs (Buttari et al., 2017). Here, IFNG is linked to myeloid sarcoma.